08:00-08:20 | Faculty |
Inborn Errors of Immunity in Interleukin-6 Cytokine Family Signalling |
|
||||
08:20-08:40 | Faculty |
Genetic Mutations in Pediatric Patients with Inflammatory Bowel Disease |
|
||||
08:40-08:50 | Speaker |
Comprehensive Genetic and Immunological Analyses Reveal the Involvement of Inborn Errors of Immunity in Pediatric IBD: A Japanese Multicenter Study |
|
||||
08:50-09:00 | Speaker |
The Mechanism of a Novel Variant in TCIRG1 on Mouse Model of Infantile Malignant Osteopetrosis |
|
09:00-09:20 | Faculty |
Somatic Mutations in Autoinflammatory and Autoimmune Diseases (Format: Virtual) |
|
||||
09:20-09:40 | Faculty |
JAK Inhibitor Treatments for Inborn Errors of Immunity |
|
||||
09:40-09:50 | Speaker |
Screening Programme Providing Outreach for Testing Hereditary Angioedema (SPPOT-HAE): Validation and Utilizing Dried Blood Spots for Family Screening |
|
||||
09:50-10:00 | Speaker |
Combined Immunodeficiency Caused by PTPRC Mutation |
|
11:00-11:20 | Faculty |
A Multi-omics Understanding of Thymus Development and Function |
|
||||
11:20-11:40 | Faculty |
The Potential Applications of Extracellular Vesicles in Inborn Errors of Immunity |
|
||||
11:40-11:50 | Speaker |
Inborn Errors of Immunity in the Himalayan Region – A Multi-center Study |
|
||||
11:50-12:00 | Speaker |
Transcriptional Regulatory Mechanism of Autoimmunity Promoted by STAT1-GOF Mutation |
|
12:00-12:20 | Faculty |
Management of Inflammasomopathy |
|
||||
12:20-12:40 | Faculty |
Deficiency of Adenosine Deaminase 2: Consensus and Controversies in 2025 |
|
||||
12:40-12:50 | Speaker |
Unraveling the Genetic Landscape of Early-Onset Systemic Lupus Erythematosus in India: Insights from a Large Cohort Study of 365 Patients |
|
||||
12:50-13:00 | Speaker |
Effectiveness of Sirolimus in Early On-Set Autoimmune Cytopenias of Autoimmune lymphoproliferative immunodeficiencies (ALPIDs) |
|
13:00-13:20 | Faculty |
What's New on Monogenic Vasculitis? (Format: Virtual) |
|
||||
13:20-13:40 | Faculty |
Unlocking the Frontier Progress and Clinical Practice of Clinical Diagnosis and Treatment of Pediatric Vasculitis (Language: Chinese) |
|
||||
13:40-14:00 | Faculty |
Centralized Rare Disease Diagnosis Service and Decentralized Product Solution for Screening Applications (Language: Chinese) |
|
||||
14:00-14:20 | Faculty |
Changing the Outcome of Disease Treatment and Opening a New Chapter in Childhood Lupus Disease Modification (Format: Virtual) |
|
||||
14:20-14:32 | Speaker |
Good Is Bad: Repeated Infections and Intrathoracic Mass in a 44-Year-Old Woman (Format: Virtual) |
|
||||
14:32-14:44 | Speaker |
A Journey Beyond the Conventional for a Patient's Chronic Gastrointestinal Inflammation (Format: Virtual) |
|
14:30-14:50 | Faculty |
Management of IgG4-related Diseases |
|
||||
14:50-15:10 | Faculty |
Cryopyrin-associated Periodic Fever Syndrome in Japan |
|
||||
15:10-15:20 | Speaker |
Genetically Defined Systemic Autoinflammatory Diseases in Pediatric Patients with Behçet's Disease |
|
||||
15:20-15:30 | Speaker |
Monogenic Pediatric Systemic Autoinflammatory Diseases in Nepal-Maiden Himalayan Cohort |
|
16:30-16:50 | Faculty |
The Role of Innate Immunity in Pediatric Neurological Disorders |
|
||||
16:50-17:10 | Faculty |
Severe Combined Immunodeficiencies Due to Defects in V(D)J Recombination |
|
||||
17:10-17:20 | Speaker |
Implementation of a Territory-wide Newborn Screening Program for Severe Combined Immunodeficiency in Hong Kong: Experience from Our 3-year Program |
|
||||
17:20-17:30 | Speaker |
Developing Laboratory Support for the Diagnosis of PIDs in Bangladesh: Past, Present and Future |
|
17:30-17:50 | Faculty |
Monogenic Lupus |
|
||||
17:50-18:10 | Faculty |
Current Therapeutic Approaches to Activated PI3K Delta Syndrome (APDS) |
|
||||
18:10-18:20 | Speaker |
Type-1 Interferon Signature in Patients with Chronic Granulomatous Disease |
|
||||
18:20-18:30 | Speaker |
The Efficacy of Dupilumab in Treatment of Atopic Dermatitis in Children with STAT3-loss-of-function Hyper-immunoglobulin E (STAT3-HIES) Syndrome |
|